Decreased serum caspase-3 levels in women with diagnosed cancer may be related to decreased release of the enzyme from tumor cells due to disturbances in the executive phase of apoptosis, which may result from abnormal expression of initiator caspases that activate caspase-3 or a direct effect on this enzyme. The gene discussed is CASP3; the disease is cancer.